Sale!

GJA8 Gene Cataract-Microcornea Syndrome Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GJA8 Gene Cataract-Microcornea Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the GJA8 gene, which are linked to the development of Cataract-Microcornea Syndrome. This genetic condition is characterized by the presence of cataracts along with microcornea, a condition where the cornea’s diameter is less than 10 mm in both eyes, potentially leading to visual impairment.

The test is conducted through a detailed analysis of the patient’s DNA to identify any genetic alterations in the GJA8 gene, which plays a crucial role in the development and maintenance of eye lens transparency and corneal size. Identifying mutations in this gene can help in confirming the diagnosis, understanding the risk of transmitting it to offspring, and potentially guiding treatment and management decisions for affected individuals.

At DNA Labs UAE, the cost of the GJA8 Gene Cataract-Microcornea Syndrome Genetic Test is set at 4400 AED. The test provides a crucial resource for families and individuals at risk of this genetic syndrome, offering insights that can lead to early intervention and personalized care plans to manage the condition effectively.

Description

GJA8 Gene Cataract-microcornea Syndrome Genetic Test

Test Name: GJA8 Gene Cataract-microcornea Syndrome Genetic Test

Components: GJA8 gene sequencing

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Ophthalmology Disorders

Doctor: Ophthalmologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for GJA8 Gene Cataract-microcornea Syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GJA8 Gene Cataract-microcornea Syndrome NGS Genetic DNA Test gene GJA8.

Test Details: The GJA8 gene is associated with cataract-microcornea syndrome, a rare genetic disorder characterized by the presence of cataracts and abnormally small corneas. NGS genetic testing can be used to identify mutations in the GJA8 gene that are responsible for this condition. This type of testing involves sequencing the entire gene to identify any changes in the DNA sequence that may be causing the disorder. The results of the test can help to confirm a diagnosis of cataract-microcornea syndrome and provide information about the inheritance pattern of the condition. This information can be used to help affected individuals and their families understand the risks of passing the disorder on to future generations and to make informed decisions about family planning and medical management.

Test Name	GJA8 Gene Cataract-microcornea syndrome Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Ophthalmology Disorders
Doctor	Ophthalmologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for GJA8 Gene Cataract-microcornea syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GJA8 Gene Cataract-microcornea syndrome NGS Genetic DNA Test gene GJA8
Test Details	The GJA8 gene is associated with cataract-microcornea syndrome, a rare genetic disorder characterized by the presence of cataracts and abnormally small corneas. NGS genetic testing can be used to identify mutations in the GJA8 gene that are responsible for this condition. This type of testing involves sequencing the entire gene to identify any changes in the DNA sequence that may be causing the disorder. The results of the test can help to confirm a diagnosis of cataract-microcornea syndrome and provide information about the inheritance pattern of the condition. This information can be used to help affected individuals and their families understand the risks of passing the disorder on to future generations and to make informed decisions about family planning and medical management.